Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Other financing activities (2021 - 2025)

Senti Biosciences has reported Other financing activities over the past 3 years, most recently at $12000.0 for Q3 2025.

  • Quarterly results put Other financing activities at $12000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $2.5 million (up 978.17% YoY), and the annual figure for FY2025 was $2.5 million, up 2369.0%.
  • Other financing activities for Q3 2025 was $12000.0 at Senti Biosciences, down from $533000.0 in the prior quarter.
  • Over the last five years, Other financing activities for SNTI hit a ceiling of $1.9 million in Q1 2025 and a floor of $12000.0 in Q3 2025.
  • Median Other financing activities over the past 3 years was $523430.0 (2021), compared with a mean of $609755.7.